The production of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Preliminary routes focused on protein fragment coupling, utilizing https://murrayzjdi258686.blogsidea.com/47477491/synthesis-and-investigation-uses-of-retatrutide